超级碰在线-超级碰碰永久免费视频播放-超级碰碰碰免费视频播放-超级碰碰碰免费视频-亚洲国产99在线精品一区69堂-亚洲高清资源在线观看

英國AbD Serotec   
Serotec公司成立于1982年，總部位于英國牛津。2006年初由原來的Serotec、Design、Biogenesis和OBT四家公司合并而成AbD Serotec，統一歸德國著名的抗體公司旗下。合并后的AbD Serotec公司可以提供上萬種抗體和免疫學試劑、單抗制備和多種規模的抗體生產和標記服務。最近AbD Serotec還建立了ISO 9001認證的生產機構，為其客戶提供更高品質的免疫學產品和相關客戶服務。
在美國、德國、斯堪的納維亞半島等設有分公司，還擁有全世界范圍內的代理商。其宗旨為生產高質量的抗體和免疫學試劑以滿足廣大客戶日益增長的需求。Serotec不斷地有計劃的對其產品系進行擴展，迄今為止世界范圍內提供的試劑達數千種之多。

該公司擁有最好的大鼠CD68單抗(克隆號:ED1);同時,抑制素A檢測試劑盒為該公司專利產品.

Serotec主要產品系：
· Human CD
· Rodent
· Veterinary
· Cell biology and Apoptosis
· Flow Cytometry
· Immunohistology
· Secondary Reagents

其中大鼠抗體和各種動物研究試劑，Serotec在全世界處于領先地位



AbD (Antibodies Direct) is the research antibody division of MorphoSys, one of the world’s leading antibody technology companies.

The AbD Serotec brand was created in early 2006 to market the combined products and services of Antibodies by Design, Biogenesis, Serotec, and Oxford Biotechnology – more than 10,000 antibodies and immunological reagents, custom monoclonal antibodies developed from the MorphoSys HuCAL library, and large and small scale antibody production and conjugation services.

AbD Serotec prides itself on its commitment to providing its customers in research and industry the highest quality products and services, and has recently opened a new ISO 9001-certified production facility in Kidlington, near Oxford UK. This new facility is the AbD Serotec headquarters, and supports sales offices in Raleigh, North Carolina; Brentwood, New Hampshire; Duesseldorf, Germany; Paris, France; and Hamar, Norway. Custom monoclonal development services are performed at MorphoSys headquarters in Martinsried, near Munich in Germany.

MorphoSys
With its unique HuCAL technology (the Human Combinatorial Antibody Library) MorphoSys is developing the next generation of antibodies for treatment of disease and for research and diagnostics purposes. Numerous partnerships have already been entered into with well-known companies from the pharmaceutical and biotechnology sectors, such as Bayer, Boehringer Ingelheim, Centocor/Johnson & Johnson, Daiichi Sankyo, Novartis, Pfizer, Roche and Schering.

Antibodies by Design
In early 2003, MorphoSys established Antibodies by Design to provide custom antibody development services to the research and diagnostic markets using its proven HuCAL technology. The speed of this service and the high specificity of the antibodies proved extremely popular in both academia and industry, resulting in the development of more than 4000 custom monoclonal antibodies.

Biogenesis
MorphoSys acquired the Biogenesis group of companies (Biogenesis Ltd in Poole, UK, and Biogenesis Inc in Brentwood, NH, USA) in January 2005 as a vehicle to bring HuCAL antibodies into the catalog antibody market. Biogenesis brought more than 20 years experience in the antibody industry and a large and diverse range of catalog antibodies to the MorphoSys group.

Serotec
In January 2006, MorphoSys added Serotec to its Research Antibody Division, and created the AbD Serotec brand. Since its establishment more than 20 years ago, Serotec has earned a strong position in the global market for research antibodies with direct sales operations in the UK, USA, Germany, France, and Scandinavia, distributors in more than 55 countries, and a large portfolio of antibodies and custom services.

Oxford Biotechnology (OBT)
Acquired with Serotec in January 2006, OBT was an internet-based antibody sales company, with customers all over the world. The OBT product portfolio is now also part of the AbD Serotec offering.